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Protective effect of cyclosporine A in the treatment of severe hydronephrosis in a rabbit
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Background/aim: Cyclosporine A (CsA), a traditional immunosuppressive compound, has been reported to specifically prevent ischemia reperfusion tissue injury via apoptosis pathway. This study aimed to explore the renoprotective effects of CsA on the kidneys of
rabbits undergoing renal pelvic perfusion.
Materials and methods: A total of 30 rabbits were randomly assigned into a control group (n = 6) and an experimental group (n = 24).
The experimental group underwent a surgical procedure that induced severe hydronephrosis and was then stochastically divided into 4
groups (S1, S1’, S2, and S2’), consisting of 6 rabbits each. Groups S1 and S1’ were perfused with 20 mmHg of fluid, while groups S2 and
S2’ were perfused with 60 mmHg of fluid. Administration to groups S1’ and S2’ was done intravenously, with CsA once a day for 1 week
before perfusion. In the control group, after severe hydronephrosis was induced, a sham operation was performed in a second laparotomy. Acute kidney damage was evaluated using hematoxylin and eosin staining, in addition to analyzing the mitochondrial ultrastructure
and mitochondrial membrane potential (MMP). The cytochrome C (CytC) and neutrophil gelatinase-associated lipocalin (NGAL)
expression were examined immunohistochemically using Western blotting and reverse transcription-polymerase chain reaction.
Results: It was found that the renal histopathological damage was ameliorated, mitochondrial vacuolization was lower, MMP was higher, and the CytC and NGAL contents were decreased after drug intervention (groups S1’ and S2’) when compared to the experimental
groups (S1 and S2). Furthermore, there was no difference between drug intervention groups S1’ and S2’.
Conclusion: These results suggest that CsA can attenuate renal damage from severe hydronephrosis induced by renal pelvic perfusion
in rabbits. It plays a protective role in the acute kidney injury process, possibly through increased MMP and mitochondrial changes.
Key words: Hydronephrosis, cyclosporine A, kidney injury, renal pelvic perfusion, renal protection

1. Introduction
With the development of minimally invasive technology,
many types of ureteroscopy and percutaneous nephroscope lithotripsy have become routine procedures in surgical intervention for kidney stones, as they have several
advantages, including reduced postsurgical pain, efficient
stone clearance, shorter hospitalization time, and reduced
scar formation than open surgery [1,2]. However, minimally invasive surgery in the kidney may not be minimally
invasive within the kidney itself. Endourological operations need sufficient fluid perfusion to clearly flush out kidney stone fragments during these procedures, due to the
limitations of the orifices [3]. These procedures can cause
high intrapelvic pressure and pyelovenous backflow when
the pressure increases to a certain extent, which could reduce renal arterial perfusion and lead to renal ischemic
injury [4,5]. In addition, there is a certain degree of hy-

dronephrosis in patients with upper urinary tract stones.
A previous study demonstrated that a 60 mmHg renal pelvic perfusion substantially aggravated kidney damage in a
rabbit model of hydronephrosis via mitochondrial injury
[6]. Nevertheless, effective protection for hydronephrotic
kidneys after renal pelvic perfusion has not yet been studied.
Cyclosporine A (CsA), known as an immunosuppressive compound, has been traditionally used to prevent
and treat transplant rejection [7]. Recently, CsA has been
thought to specifically prevent mitochondrial permeability
transition pore (mPTP) opening and attenuate cell apoptosis by exerting cardioprotective effects in a reperfusion
injury model [8]. Moreover, previous studies have shown
that CsA protects against tissue ischemia-reperfusion injury in the brain [9], lung [10], and kidney [11] in vivo.
However, whether CsA affects renal pelvic perfusion-in-
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duced hydronephrotic kidney injury in vivo is unknown.
Although CsA is known as a nephrotoxic drug, a low dose
of CsA was safe and effective in animal models, according
to previous experimental studies [12].
Herein, it was speculated that severe hydronephrosis can cause renal parenchymal ischemic injury, based
on rabbit models involving renal pelvic perfusion of 60
mmHg, as well as mitochondrial damage in renal tubular epithelial cells. Hence, the mPTP inhibitor CsA was
chosen to pretreat large white rabbits in an experimental
group in order to observe the renoprotective effects of CsA
on kidneys undergoing pelvic perfusion.
2. Materials and methods
2.1. Animals and groups
A total of 30 adult New Zealand white rabbits (1.9–
2.3 kg) were received from the Wuhan Institute of
Biological Products Co., Ltd. (Wuhan, China). All of the
procedures were approved by the Animal Experimental
Ethics Committee of Wuhan University (Wuhan, Hubei,
China). All of the rabbits were stochastically assigned
into a control group (n = 6) and an experimental group
(n = 24). Severe hydronephrosis was induced in the
experimental group via surgery and the rabbits were then
stochastically divided into 4 groups (S1, S1’, S2, and S2’),
consisting of 6 rabbits each, after successful molding
by B ultrasonic examination. Groups S1 and S1’ were
perfused with 20 mmHg of fluid, while groups S2 and S2’
were perfused with 60 mmHg of fluid. Groups S1’ and
S2’ were administered CsA intravenously once a day for
1 week before the perfusion. In the control group, after
severe hydronephrosis was induced, a sham operation was
performed in a second laparotomy. Acute kidney injuries
were evaluated by hematoxylin and eosin (HE) staining,
in addition to analyzing the mitochondrial ultrastructure
and mitochondrial membrane potential (MMP). CytC
expression was analyzed immunohistochemically and the
NGAL expression was examined using Western blotting.
2.2. Surgical manipulation
Rabbits in the experimental and control groups underwent
an operation to induce severe hydronephrosis according
to a previous method [13]. The animals were anesthetized
using pentobarbital [30 mg/kg, intravenously (i.v.)] via the
marginal vein of the ear. They were fixed in a supine position. After a midline abdominal incision, the left lumbar vein, left ureter, and psoas muscle were exposed. The
upper two-thirds of the ureter was covered by the psoas
muscle, and the muscles were sutured over the ureter. Two
weeks after surgery, B-ultrasonography was performed
to evaluate hydronephrosis. Pelvic distention was 1.72 ±
0.38 cm, while the thickness of the parenchyma was 0.21
± 0.03 cm. After hydronephrosis was confirmed, groups
S1’ and S2’ were administered CsA (2.5 mg/kg, i.v.) once
a day for 1 week. The dose of CsA used was safe and effec-

tive in animal models according to a previous study [12].
Next, the second laparotomy was performed. The left kidney was revealed, and subsequently, a size 4.5 needle was
embedded approximately 0.4 cm into the parenchyma. After that, a pressure pump and physiological recorder were
connected to maintain and detect the intrapelvic pressure.
Before perfusion, the intrapelvic pressures were measured
in the severely hydronephrotic kidneys and were found to
be 16.35 ± 1.85 mmHg. Groups S1 and S2 were irrigated at
20 and 60 mmHg with warm isotonic saline for 8 min. The
irrigation was then paused for 2 min. This procedure was
carried out for 4 times. In the end, the sutured ureter was
released, and the abdominal median incision was sutured.
For the control group, the hydronephrotic kidney was only
exposed without perfusion in the second laparotomy. The
rabbits were euthanized by air injection 48 h after that, and
then, the left renal tissue specimens were immediately separated to analyze the MMP and mitochondrial ultrastructure. Partial tissue specimens for the immunohistochemical analyses were embedded in paraffin, while the other
kidney tissues were frozen at –80 °C until performing the
Western blot analysis.
2.3. HE staining
After 10% formalin fixation, the renal tissues were processed routinely for paraffin embedding and cut into 5-μm
slices. After general dewaxing and hydration, the slices
were then stained with HE.
2.4. Kidney ultrastructure by transmission electron microscopy
Tissues were dissected and fixed with 2.5% glutaraldehyde,
rinsed in 0.1 M phosphate buffer 3 times, postfixed in 1%
buffered osmium tetroxide, and rinsed in 0.1 M phosphate
buffer. Next, the tissues were dehydrated by incubating the
tissue in graded alcohol, and the dehydrated tissue was put
into epoxy resin. Thin tissue sections were cut using an ultramicrotome (LKB, Bromma, Kista, Sweden) and stained
with uranyl acetate and lead citrate. A transmission electron microscope was used to observe any ultrastructural
changes (H-600, Hitachi, Tokyo, Japan). Mitochondrial
morphology changes were determined in images from 3–5
random fields in each group for the calculation of the percentage of vacuolar mitochondria.
2.5. MMP detection
MMP was detected using 5,5’,6,6’-tetrachloro-1,1’,3,3’tetr
aethylbenzimidazolycarbocyanine iodide (JC-1, Beyotime
Institute of Biotechnology, Jiangsu, China). Kidney tissue
was digested in a trypsin-ethylene-diamine-tetraacetic
acid (EDTA) solution (Beyotime Institute of Biotechnology). Subsequently, the bovine serum was added to end
digestion. Suspended cells were harvested and loaded with
1×JC-1 at 37 °C for 20 min, and then, the cells were washed
and detected by flow cytometry (FACS Aria III, BD, New
Jersey, US). When the MMP is at a low level, JC-1 exists
mainly as a monomer that emits green fluorescence (ex-
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citation wavelength of 488 nm and emission wavelength
of 530 nm). When the MMP is at a high level, JC-1 exists
mainly as a polymer that emits red fluorescence (excitation
wavelength of 525 nm and emission wavelength of 590
nm). For data presentation, the value of the MMP was expressed as the intensity ratio of red to green fluorescence.
2.6. Immunohistochemical staining
Briefly, the kidney tissues were paraffin-embedded, sectioned, fixed, and dehydrated. Endogenous enzymes were
deactivated by applying 0.3% hydrogen peroxide for 10
min at 37 °C. Microwave antigen retrieval of the CytC and
NGAL was performed on the rehydrated slides in a citric acid buffer solution and Tri/EDTA buffer solution for
15 min. Samples were incubated with a primary antibody
against CytC and NGAL (Univ-Biotechnology, Shanghai,
China) overnight at 4 °C. Next, the secondary antibodies
were added, and the samples were incubated. After redying, purifying, dehydrating, and cleaning, the samples
were observed under a microscope. The immunostaining
scores were conducted according to the manufacturer’s
recommendations.
2.7. Western blotting
The protein levels of the NGAL were detected using the
Western blotting analysis. Briefly, the bicinchoninic acid
method was used to measure protein concentrations, and
the kidney proteins (10 µg) were separated by electrophoresis in 10% sodium dodecyl sulfate polyacrylamide
gels. Proteins in the gels were transferred to nitrocellulose membranes. The membranes were then probed with
antiNGAL polyclonal antibodies (1:500; Bioss Biological
Technology Co., LTD, Beijing, China) and antiCytc monoclonal antibodies (1: 2000; Bioss Biological Technology
Co.) for rabbit proteins. HRP-conjugated goat antirabbit IgG antibodies (Cell Signaling Technology, Shanghai,
China) were applied as secondary antibodies (1: 10,000).
The relevant protein bands were visualized by enhanced
chemiluminescence reagents and analyzed with the Odyssey image analysis system. To determine an equal content
of proteins for each sample, the membranes were reprobed
with mouse anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) polyclonal antibodies (1: 5000, Cell Signaling Technology). The result was expressed as the ratio
of target protein to GAPDH.

2.8. Reverse transcription-polymerase chain reaction
(RT-qPCR)
The total RNA was extracted from the renal tissues from
the 5 groups using TRIzol reagent (Invitrogen; Thermo
Fisher Scientific Inc., Waltham, MA, USA), while the RNA
concentrations were determined spectrophotometrically.
First-strand cDNA was synthesized using a cDNA synthesis kit (Promega Corporation, Madison, WI, USA) based
on the manufacturer’s instructions. The RT-qPCR was
used with the SYBR Green mix kit (Applied Biosystems;
Thermo Fisher Scientific Inc.). The primers for Cytc and
NGAL were designed as follows: Cytc sence, 5’-GAGCACCTTCTTTTCCTTCATCTT-3’,
and
antisense,
5’-TCACACACCAGCAGGTTATCATC-3’; and NGAL
sence, 5’-ATGCTTCAGACCTCCCTT-3’, and antisense,
5’-CTCCACCAACTATCTCCACT-3’. GAPDH was taken
as a housekeeping gene. The data were measured as a proportion of the gene to GAPDH mRNA (sense, 5’-ACAGCAACAGGGTGGTGGAC-3’, and antisense, 5’-TTTGAGGGTGCAGCGAACTT-3’). PCR was processed with
40 cycles at 92 °C for 30 s, 55 °C for 30 s, and 70 °C for
25 s, using the RT-qPCR instrument (ABI StepOnePlus;
Thermo Fisher Scientific Inc.).
2.9. Statistical analysis
All data were presented as the mean ± SD. Statistical analyses were conducted using SPSS 17.0 (IBM Corp., Armonk,
NY, USA). For comparisons of the parameters among the
groups, 1-way analysis of variance was conducted after the
normality tests and tests for homogeneity of variance. A
difference was considered significant at P < 0.05.
3. Results
3.1. CsA ameliorated the histopathological damage in
hydronephrotic kidney after perfusion
Hydronephrotic renal tissue histopathological changes
in the HE staining after perfusion were observed by
light microscopy. In the control group, no substantial
morphological changes were observed. Renal pelvic
perfusion resulted in significant damage that was
represented by a swollen glomeruli and tubule cells, renal
tubule dilatation, and inflammatory cell infiltration in
groups S1 and S2. However, following intervention with
CsA, there were fewer swollen and dilated cells in groups
S1’ and S2’ than in groups S1 and S2 (Figure 1).

Figure 1. Histopathological changes in the rabbit kidneys. HE staining images of the kidney shows the swollen glomeruli and tubule
cells and renal tubule dilatation (x200).

1592

ZHOU et al. / Turk J Med Sci
3.2. CsA ameliorated the ultramicrostructure damage in
hydronephrotic kidney after perfusion
Left hydronephrotic renal tissue ultrastructural changes
after perfusion were observed by transmission electron
microscopy. Swollen and vacuolar mitochondria of the renal tubular epithelial cells were rare in the control group.
Renal pelvic perfusion resulted in significant mitochondria damage that was represented by seriously swollen
mitochondria and a large number of vacuolar changes,
as well as endoplasmic reticulum expansion in groups S1
and S2. However, following intervention with CsA, there
were fewer swollen and vacuolar mitochondria in groups
S1’ and S2’ than in groups S1 and S2 (P < 0.05). There was
no significant difference between the CsA intervention
groups (P > 0.05) (Figure 2).
3.3. CsA increased the MMP levels in hydronephrotic
kidney after perfusion
To determine the influence of CsA on the biomarkers of
early apoptosis in the rabbit hydronephrotic kidneys after
renal pelvic perfusion, MMP levels were measured using
flow cytometry and JC-1 staining. The stained cells were
divided into 4 subpopulations, as: section Q1, showing
normal mitochondrial polarization; section Q3, showing dead cells or debris; section Q2, showing normal
mitochondrial polarization and cells with mitochondrial

depolarization; and section Q4, which represented mitochondrial depolarization. MMP values were presented as
the proportion of section Q2 intensity to section Q4 intensity. According to the flow cytometric analysis, renal pelvic
perfusion decreased the MMP levels in groups S1 and S2,
but the CsA treatment effectively mediated increases in
the MMP levels in groups S1’ and S2’ when compared to
groups S1 and S2 (P < 0.05). There were no significant differences between the CsA intervention groups (P > 0.05)
(Figure 3).
3.4. CsA reduced the apoptosis of hydronephrotic kidney
after perfusion
To explore the effect of CsA on apoptosis inhibition, the
levels of CytC and NGAL in the rabbit hydronephrotic
kidneys after renal pelvic perfusion were assessed
immunohistochemically, and with Western blot analysis
and RT-qPCR. The immunohistochemistry staining
indicated that the rabbits in groups S1 and S2 displayed
increased levels of CytC and NGAL, whereas the CsA
treatment significantly lowered the levels of CytC and
NGAL in groups S1’ and S2’, respectively (P < 0.05) (Figure
4). As expected, the Western blot analysis and RT qPCR
showed that the CsA markedly reduced the protein and
mRNA expression levels of the CytC and NGAL (Figures
5 and 6).

Figure 2. Ultrastructural changes in the mitochondria of the renal cells. (A) Transmission electron microscopy shows the vacuolar and
swollen mitochondria in rabbits (×5000). (B) Quantification of the vacuolar and swollen mitochondria in rabbits. The bars represent the
means ± SD; #P < 0.05 vs. S1 group, ※P < 0.05 vs. S2 group, ▲P > 0.05 vs. S1’ group.
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Figure 3. Mitochondrial membrane potential (MMP) changes in the renal cells. (A) Renal cell MMP changes analysis by flow cytometry.
MMP levels are represented as the ratio of Q2 intensity to Q4 intensity. (B) Quantification of renal cell MMP in rabbits. The bars
represent the means ± SD; #P < 0.05 vs. S1 group, ※P < 0.05 vs. S2 group, ▲P > 0.05 vs. S1’ group.

4. Discussion
Instead of traditional open surgery, flexible ureteroscope
and percutaneous nephrolithotomy have been extensively
applied to treat urolithiasis. These endourological surgeries,
which occur in a closed cavity during the procedure, need
sufficient fluid perfusion to acquire a clear operational
visual field. The normal renal pelvis internal pressure
is approximately 7.5 mmHg. According to a previous
report [5], pyelovenous lymphatic backflow could occur
with an intrapelvic pressure of more than 30 mmHg.
Venous outflow obstruction can result in the formation
of microthrombosis, which then affects the blood supply
of the renal parenchyma. Essentially, kidney damage
becomes an ischemic injury when severe hydronephrosis
is subjected to a certain degree of perfusion [4,6].
In a previous experiment, it was observed that kidney
damage became serious when the degree of perfusion
pressure of severe hydronephrosis reached 60 mmHg [6].
Kidney damage differed depending on whether the renal
pelvis was perfused with pressures of 20 or 60 mmHg. The
difference was statistically significant. This is the reason why
these 2 different perfusion pressures were selected in the
present study. Swollen and damaged glomeruli and tubule
cells, an increase in swollen mitochondria, and decreased

1594

MMP were observed in the severe hydronephrosis
group when the perfusion pressure reached 60 mmHg.
At the same time, a higher apoptosis rate and higher
expression of apoptosis factors were observed in the severe
hydronephrosis group than in the group perfused with a
pressure of 20 mmHg. One mechanism by which the MMP
can decrease apoptosis is the opening of the mPTP; thus,
it was speculated that mitochondrial-mediated apoptosis
played a dominant role in the severe hydronephrosis
group. It was possible that mPTP opening and closing
played a vital role in the mechanism associated with the
changes in mitochondrial permeability. mPTP opening is
an early sign of cell apoptosis [14]. Many methods have
been applied to prevent mPTP opening and the consequent
mitochondria-driven apoptosis or cell death [15–17].
In the process, the CsA has reached the certain clinical
stage. Many animal experiments have confirmed that CsA
has therapeutic effects on myocardial infarction [18–21]
and neurogenic [22,23] ischemic injuries. A variety of
research has reported that treatment with CsA during
percutaneous coronary intervention induced reperfusion
that was related to a smaller infarct by some measures
when compared to the placebo [20]. The present study also
demonstrated that CsA ameliorated the histopathological
damage in hydronephrotic kidneys after perfusion.

ZHOU et al. / Turk J Med Sci

Figure 4. Expression of CytC and NGAL in the kidneys by immunohistochemical staining. (A) CytC and NGAL expression (×200); the
brown fields in the cytoplasm represent the CytC and NGAL expression. (B) Quantification of the immunostaining scores of the CytC
and NGAL expression in rabbits. The bars represent the means ± SD; #P < 0.05 vs. S1 group, ※P < 0.05 vs. S2 group, ▲P > 0.05 vs. S1’
group.

Figure 5. Renal protein expression changes in the Cytc and NGAL in the kidney. (A) Expression of Cytc and NGAL in the kidneys by
western blotting. (B) Quantification of the Cytc and NGAL expression in rabbits. The bars represent the means ± SD; #P < 0.05 vs. S1
group, ※P < 0.05 vs. S2 group, ▲P > 0.05 vs. S1’ group.

CytC is located between the mitochondrial internal
and external membranes. The increased open probability
of mPTPs causes CytC to be released into the cytoplasm
in the context of various stress factors, whereupon

it combines with apoptosis protein activated factor
(Apaf21) and adenosine triphosphate (ATP) as compound
factors. These protein complexes activate the apoptotic
protease cascade and mediate renal tubular epithelial cell
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Figure 6. Renal mRNA expression changes in the Cytc and NGAL in the kidney. Expression of Cytc and NGAL in the kidneys by RTqPCR. The bars represent the means ± SD; #P < 0.05 vs. S1 group, ※P < 0.05 vs. S2 group, ▲P > 0.05 vs. S1’ group.

apoptosis through caspase-dependent pathways, leading
to impaired renal function [24]. In the present study,
when compared with the experimental groups, the CsA
intervention showed less mitochondrial vacuolization
and expression of CytC, increased MMP in the renal
tubular epithelial cells, and no difference between the
drug intervention groups, indicating improved renal
function. This showed that CsA played a protective role
in maintaining the permeability and the integrity of the
mitochondria. Reduced mitochondrial transmembrane
potential indicated mPTP opening. As cells lose MMP,
the inflow of micromolecules results in vacuolization and
mitochondrial swelling, which then induces mitochondrial
collapse, cell death, and a decrease in ATP synthesis [25–
27]. In this experiment, CsA in rabbits was used to inhibit
the decline in MMP and reduce mitochondrial membrane
permeability in the renal tubular epithelial cells. Thus, the
release of proapoptotic factors in the mitochondria was
reduced, leading to reduced mitochondrial swelling and
vacuolization. The results above implied that CsA could
reduce kidney damage through an extensive mitochondrial
protective effect.
NGAL is poorly expressed in normal kidney tissues.
Nevertheless, it shows high expression in the proximal
renal tubule during ischemic renal injury. NGAL is a
sensitive and steady biomarker of renal tubule damage that
is routinely used to predict kidney injury [28]. Within 3 h
after kidney injury, the expression of NGAL was increased
in the proximal tubule, and it was released into the plasma
within 12 h. In this experiment, less NGAL expression
was observed in the CsA intervention groups than in
the experimental groups. While, there was no significant
difference between the CsA intervention groups, these
results suggested that CsA played a renoprotective role
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during renal pelvis perfusion through the attenuation of
renal tubular damage.
CsA becomes a key component of the transplantation
immunosuppressive complex by binding to cytosolic
cyclophilin A. Additionally, CsA links to the cyclophilin
D component of mPTP and inhibits mPTP opening. There
is a general agreement that most ischemic injury of organs
is associated with mitochondrial damage. Therefore,
mitochondria are considered as a therapeutic target to
prevent cellular injury after ischemic injury. Recent reports
have shown the effects of CsA on the heart and brain
[18–22]. In addition, a study found that the inhibition
of cyclophilin D attenuated calcium transfer from the
endoplasmic reticulum to the mitochondria in ischemiareperfusion injury [29], as accumulated cytosolic calcium
can enhance the sensitivity of the mPTP. Moreover,
the protection effect of CsA in ischemia injury was also
found to be associated with inhibiting the translocation
of the nuclear factor of activated T cells or preventing the
dephosphorylation of NOS [9,30,31]; however, the specific
mechanism remains unknown and further investigation is
needed.
In summary, this research provided evidence
demonstrating that CsA can attenuate the renal damage
of severe hydronephrosis due to renal pelvic perfusion
by reducing mitochondrial injury. Drug prevention of
mitochondrial injury would be a potential therapeutic
approach to treat the renal pelvic perfusion-induced renal
damage from severe hydronephrosis.
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